Skip to main content
SpringerLink
Log in

Analysis in the Vioxx APPROVe trial corrected

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators.Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. Correction. New England Journal of Medicine 355: 221, No. 2, 13 Jul 2006

  2. Merck and Co Inc.An open letter from Merck. Company Communication: [5 pages], 26 Jun 2006. Available from: URL: http://www.merck.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Analysis in the Vioxx APPROVe trial corrected. React. Wkly. 1109, 1 (2006). https://doi.org/10.2165/00128415-200611090-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200611090-00001

Keywords

Search

Navigation